Beta-blockers prevent death from CHF
Beta-blockers prevent death from CHF
Beta-blockers reduce deaths among patients with congestive heart failure by 31%, according to a meta-analysis of 17 randomized clinical trials that included a total of 3,039 patients. The treatment proved most effective in preventing progressive, nonsudden cardiac death, reducing the odds by 42% for patients receiving beta-blocker therapy. It reduced sudden death by 16%.
The improved survival was unrelated to the cause of heart failure. Most of the studies in the meta-analysis followed patients for one year or less, so researchers noted that they could not comment on the effect of beta-blockers on long-term survival.
Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials. Journal of the American College of Cardiology 1997; 30:27-30.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.